Life Sciences - Asia-Pacific Region
What the team is known for
King & Wood Mallesons acts on a broad range of matters in the life sciences space in China and Australia, including IP, regulatory work, financing and dispute resolution. The firm is particularly well versed in anti-bribery investigations in the biopharma and medical devices sectors. It is also able to draw on the resources of a noted corporate practice for support on financing, restructuring, IPO and M&A transactions in this practice area. The firm maintains a large network of offices across the region, including in Hong Kong, Japan and Singapore.
Strengths
"They are a pleasure to work with; we are always briefed by them because everything is well prepared. They have a big team and they work well together."
Work highlights
King & Wood Mallesons acted for the University of Sydney on a claim by its employed researchers that it had failed to properly commercialise intellectual property which was comprised in a clinical trials database.
Notable practitioners
Matthew Swinn and Kim O'Connell are key contacts in Australia and Beijing-based Zhu Nongfan is the main contact in China.
